Physician profile
Jonah J Stulberg
NPI 1831416544
$208,623.95
in general payments reported to CMS, 2019-2025
22 companies · $30K in 2025
The $30K reported for 2025 was more than what 98% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $66K · 2020: $34K · 2021: $29K · 2022: $19K · 2023: $17K · 2024: $14K · 2025: $30K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $42K · Food and Beverage: $8,317 · Travel and Lodging: $6,295 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,000 · Consulting Fee: $300 · Gift: $16.25.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $41,800.00 |
| Food and Beverage | $8,317.12 |
| Travel and Lodging | $6,295.25 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,000.00 |
| Consulting Fee | $300.00 |
| Gift | $16.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $187,809.26 | 2019-2025 | Da Vinci Surgical System, Da Vinci Sp |
| Covidien LP | $4,079.26 | 2020 | |
| Mesh Suture INC | $3,437.04 | 2024-2025 | |
| Davol INC. | $2,833.04 | 2019-2025 | Phasix Mesh, Arista Ah Flexitip |
| Medtronic, INC. | $2,031.89 | 2022-2025 | Signia, Ligasure |
| Distalmotion US | $1,981.20 | 2024-2025 | Dexter L6 Robot |
| Tela Bio, INC. | $1,661.70 | 2023-2025 | Ovitex 2s, Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Integra Lifesciences Corporation | $831.76 | 2022-2025 | Integra, Integra Dermal Regeneration Template, Surgimend |
| W. L. Gore & Associates, INC. | $729.87 | 2019-2025 | Gore Synecor Biomaterial, Gore Enform Intraperitoneal Biomaterial, Seamguard |
| Baxter Healthcare | $685.57 | 2022-2025 | Perclot, Tisseel, Floseal |
| Ethicon US, LLC | $578.45 | 2021-2025 | Vistaseal, Echelon Flex, Stratafix |
| Kerecis Limited | $369.63 | 2024-2025 | Kerecis Omega3 Marigen, Kerecis Surgiclose, Kerecis Omega3 Surgiclose |
| Allergan, INC. | $335.36 | 2021-2022 | |
| Acera Surgical, INC. | $270.27 | 2024 | Restrata Wound Matrix |
| Abbvie INC. | $258.20 | 2023-2025 | Alloderm |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $223.76 | 2023-2024 | Oasis, Stravix, Grafix Pl |
| Boston Scientific Corporation | $172.40 | 2022-2025 | Spyglass Discover |
| Becton, Dickinson and Company | $142.16 | 2024-2025 | Phasix Mesh |
| Stryker Corporation | $117.64 | 2024 | Spy-Phi System, Switchpoint Infinity, Isuite, 1788 |
| Aroa Biosurgery Incorporated | $27.25 | 2024 | |
| Teleflex LLC | $24.24 | 2025 | Quikclot |
| Conmed Corporation | $24.00 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonah Stulberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.